Provided by Tiger Trade Technology Pte. Ltd.

MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF

30.60
+0.48641.62%
Post-market: 30.630.0317+0.10%16:00 EDT
Volume:345
Turnover:10.55K
Market Cap:22.03M
PE:- -
High:30.60
Open:30.52
Low:30.52
Close:30.11
52wk High:32.57
52wk Low:24.64
Shares:720.00K
Float Shares:720.00K
Volume Ratio:0.32
T/O Rate:0.05%
Dividend:0.72
Dividend Rate:2.34%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Legend Biotech is Expected to Name Ingrid Zhang as Its New Chief Executive - WSJ

THOMSON REUTERS
·
Sep 15

Two Ministries Unveil 30 Trillion Yuan Plan to Supercharge Electronics Manufacturing

Deep News
·
Sep 15

Legend Biotech Updates and Expands Cell Therapy Clinical Pipeline

TIPRANKS
·
Sep 14

Legend Biotech : Barclays Cuts Target Price to $74 from $78

THOMSON REUTERS
·
Sep 11

GenScript Unit Legend Biotech to Present Updated Long-Term Carvykti Cartitude-2 Data at IMS Meeting

Reuters
·
Sep 10

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire
·
Sep 01

MEMSCAP lifts first-half profit 53% and pays inaugural dividend

TIPRANKS
·
Sep 01

MEMSCAP to Host Investor Webcast on First‑Half 2026 Results

TIPRANKS
·
Aug 26

Will Legend Biotech’s (LEGN) Move to Q2 Profitability Reshape Its Investment Narrative?

Simply Wall St.
·
Aug 26

Legend Biotech (LEGN) Turns Profitable In Q2, Is The Stock Cheap?

Simply Wall St.
·
Aug 19

Legend Biotech Sets September 24, 2026 AGM With Expanded Equity Plan on Agenda

TIPRANKS
·
Aug 19

Legend Biotech Seeks Shareholder OK to Add 19.1 Million Shares to RSU Plan Reserve

Reuters
·
Aug 19

Legend Biotech Announces Annual General Meeting

Reuters
·
Aug 19

How Legend Biotech’s Q2 Profitability Jump and Interim CEO Shift Will Impact Legend Biotech (LEGN) Investors

Simply Wall St.
·
Aug 18

Celcuity Posts Narrower-than-Expected Loss as R&D Costs Decreased

Reuters
·
Aug 14

CorMedix Beats Q2 Revenue Estimates on DefenCath Growth, Raises FY Adjusted Ebitda Guidance

Reuters
·
Aug 13

Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook

Reuters
·
Aug 13

MaxCyte Q2 Revenue Beats Estimates

Reuters
·
Aug 13

Kura Oncology Q2 Product Revenue Rises 57% on Komzifti Uptake

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live
·
Aug 13